Table 1

Baseline characteristics of randomised and surveyed samples

Randomised sample [sample 1]Short-term sample [sample 2]*Medium-term sample [sample 3]†Difference: (p values)
% / mean (n)% / mean (n)% / mean (n)[sample 2] versus [sample 1][sample 3] versus [sample 1]
Female age (years)‡24.70 (612)24.68 (484)24.68 (384)(0.940)(0.943)
Female secondary education or higher‡0.83 (435/524)0.83 (356/427)0.84 (297/353)(0.884)(0.660)
Multiparous‡0.63 (398/632)0.62 (307/497)0.63 (245/391)(0.679)(0.920)
Previous use of modern contraception0.67 (461/684)0.67 (361/536)0.66 (275/418)(0.986)(0.584)
Female preference for no future children0.30 (203/683)0.29 (157/535)0.30 (126/417)(0.887)(0.863)
Male partner preference for no future children0.21 (131/635)0.21 (106/502)0.21 (84/393)(0.842)(0.777)
Antenatal intention to use short-term postpartum contraception0.32 (215/682)0.30 (162/534)0.31 (130/416)(0.657)(0.924)
Days between study enrolment and estimated date of delivery41.53 (683)41.05 (536)39.32 (418)(0.735)(0.138)
Travel time to Jacaranda Health facility (in min)30.41 (677)30.31 (531)31.08 (415)(0.936)(0.618)
Remained in sample0.78 (537/686)0.61 (418/686)
  • Modern contraception includes the following methods: sterilisation (female or male), intrauterine devices and systems, implants, oral contraceptive pills (combined and progestin-only), emergency contraceptive pills, condoms (male/female), injectables, patches, diaphragms/cervical caps, spermicides, vaginal ring and vaginal sponge. P values generated using ordinary least squares estimation. All models include a binary variable indicating enrolment facility and a binary variable indicating study phase (1 or 2). Antenatal intention to use short-term postpartum contraception is defined as a stated baseline intention to use contraception by 9 weeks postpartum. P values generated using t-tests assuming unequal variance.

  • *Sample of participants with complete data on short-term postpartum modern family planning use.

  • †Sample of participants with complete data on medium-term postpartum modern family planning use.

  • ‡Data source is Jacaranda's electronic medical records; all other indicators collected via baseline antenatal survey.